Compositions and medical devices for controlled release of nitric oxide and methods of production thereof
US-9216198-B2 · Dec 22, 2015 · US
Use of gold nanoclusters in ameliorating oxidate stress and/or aging
US9101672B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9101672-B2 |
| Application number | US-201113218625-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 26, 2011 |
| Priority date | Aug 26, 2011 |
| Publication date | Aug 11, 2015 |
| Grant date | Aug 11, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Disclosed herein is the novel use of a gold nanocluser for ameliorating oxidative stress and/or aging of a cultured cell or a subject having an oxidative stress and/or aging condition mediated by a vascular factor. The gold nanocluster has a particle size ranging from about 0.1 to 20 nm, and preferably is dihydrolipoic acid (DHLA) coated gold nanocluster.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of ameliorating oxidative stress and/or aging of a cultured cell comprising contacting the cultured cell with about 1 to 1,000 nM of a dihydrolipoic acid (DHLA) coated gold nanocluster having a particle size ranging from about 0.1 to 20 nm, wherein, the DHLA coated gold nanocluster consists of a gold nanocluster formed by a plurality of gold nanoparticles, and a plurality of DHLAs coated on the gold nanocluster; and the cultured cell is selected f…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Operations & Transport · mapped topic
- A61K47/6923Primary
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9101672B2 cover?
- Disclosed herein is the novel use of a gold nanocluser for ameliorating oxidative stress and/or aging of a cultured cell or a subject having an oxidative stress and/or aging condition mediated by a vascular factor. The gold nanocluster has a particle size ranging from about 0.1 to 20 nm, and preferably is dihydrolipoic acid (DHLA) coated gold nanocluster.
- Who is the assignee on this patent?
- Yeh Hung-I, Chang Walter H, Lin Cheng-An, and 3 more
- What technology area does this patent fall under?
- Primary CPC classification A61K47/6923. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).